| Symbol | SLP |
|---|---|
| Name | SIMULATIONS PLUS, INC. |
| Sector | TECHNOLOGY |
| Region | North America |
| Industry | EDP Services |
| Address | 42505 TENTH STREET WEST, LANCASTER, California, 93534-7059, United States |
| Telephone | +1 661 723-7723 |
| Fax | — |
| — | |
| Website | https://www.simulations-plus.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001023459 |
| Description | Simulations Plus Inc is engaged in the software industry. It develops and produces software for use in pharmaceutical research and for education, and provides consulting and contract research services to the pharmaceutical industry. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity) Predictor is a computer program that takes molecular structures as inputs; MedChem Designer includes a small set of ADMET Predictor property predictions, allowing the chemist to modify molecular structures; MedChem Studio is a tool for medicinal and computational chemists for both data mining and for designing new drug-like molecules. Additional info from NASDAQ: |
(99% Neutral) SIMULATIONS PLUS, INC. (SLP) Announces Business Combination
Read moreSimulations Plus Announces Expiration of Hart-Scott-Rodino Waiting Period for Pending Acquisition by Altaris
Read moreSimulations Plus Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Simulations Plus, Inc. - SLP
Read moreSLP Shareholder Alert: Robbins LLP is Investigating Allegations that the Officers and Directors of Simulation Plus, Inc., Violated Securities Laws and Breached Fiduciary Duties to Shareholders
Read moreSimulation Plus, Inc. (NASDAQ: SLP) Investors Should Contact Robbins LLP for Information About Investigation
Read moreNew Form DEFM14A - Simulations Plus, Inc. <b>Filed:</b> 2026-07-22 <b>AccNo:</b> 0001023459-26-000051 <b>Size:</b> 2 MB
Read moreNew Form PRER14A - Simulations Plus, Inc. <b>Filed:</b> 2026-07-20 <b>AccNo:</b> 0001023459-26-000049 <b>Size:</b> 2 MB
Read moreDiBella John Anthony II 🔴 sold 1.0K shares of Simulations Plus, Inc. (SLP) at $18.36 Transaction Date: Jul 06, 2026 | Filing ID: 000011
Read moreDirector WOLTOSZ WALTER S 🔴 sold 4.2K shares of Simulations Plus, Inc. (SLP) at $18.44 Transaction Date: Jul 01, 2026 | Filing ID: 000012
Read moreJohnson Fistel Investigates Simulations Plus Following Revenue Guidance Cut and Accounting Disclosures
Read more